US Stock MarketDetailed Quotes
RNLX Renalytix
- 0.299
- +0.006+2.05%
Close Jul 22 16:00 ET
24.78MMarket Cap-393P/E (TTM)
0.308High0.282Low511.34KVolume0.302Open0.293Pre Close150.29KTurnover0.88%Turnover RatioLossP/E (Static)82.96MShares3.14052wk High-2.23P/B17.36MFloat Cap0.22052wk Low--Dividend TTM58.11MShs Float35.710Historical High--Div YieldTTM8.95%Amplitude0.220Historical Low0.293Avg Price1Lot Size
About Renalytix Company
Renalytix AI Plc manufactures medical devices and equipment. It offers artificial intelligence for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in Penarth, the United Kingdom.
Company Profile
SymbolRNLX
Company NameRenalytix
Issue Price13.50
Founded2018
CEOMr. James Renwick McCullough
MarketNASDAQ
Employees93
Securities TypeDR
ADS Ratio1.0 : 2.0
Fiscal Year Ends06-30
AddressAvon House,19 Stanwell Road
CityPenarth
ProvinceCardiff
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeCF64 2EZ
Phone44-20-3139-2910
Websitehttps://renalytixai.com/
Company Executives
- Name
- Position
- Salary
- James Renwick McCullough
- Chief Executive Officer and Director
- 1.04M
- Dr. Michael J. Donovan, M.D.,PhD
- Chief Medical Officer
- --
- Joel R. Jung
- Interim Chief Financial Officer and Principal Accounting Officer
- --
- Fergus Fleming
- Director and Chief Technical Officer
- --
- Christopher Harwood Bernard Mills
- Chairman of the Board
- 24.00K
- Howard B. Doran, Jr.
- President
- --
- Catherine Havlik Coste
- Director
- --
- Dr. Erik Lium, PhD
- Independent Director
- 24.00K
- Daniel Joseph Levangie
- Independent Director
- 24.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg